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Abstract 
Background: The increasing drug resistance along with inducible clindamycin resistance, methicillin resistance and 
biofilm production among the strains of Staphylococcus aureus are present as the serious problems to the successful 
treatment of the infections caused by S. aureus. So, the main objectives of this study were to determine the antimicro-
bial susceptibility patterns along with the rates of inducible clindamycin resistance, methicillin resistance and biofilm 
production among the strains of S. aureus isolated from pus/wound swab samples.
Methods: A total of 830 non-repeated pus/wound swab samples were processed using standard microbiological 
techniques. The colonies grown were identified on the basis of colony morphology, Gram’s stain and biochemi-
cal tests. Antimicrobial susceptibility testing was performed by Kirby–Bauer disc diffusion technique. Detection of 
inducible clindamycin resistance was performed by D test, while detection of methicillin resistant S. aureus (MRSA) 
was performed by determination of minimum inhibitory concentration of oxacillin by agar dilution method. Similarly, 
detection of biofilm formation was performed by microtiter plate method. Strains showing resistance to three or 
more than three different classes of antibiotics were considered multidrug resistant.
Results: Total 76 samples showed the growth of S. aureus, among which 36 (47.4%) contained MRSA and 17 (22.4%) 
samples were found to have S. aureus showing inducible clindamycin resistance. Among the S. aureus isolated from 
outpatients, 41.9% were MRSA. Highest rates of susceptibility of S. aureus were seen toward linezolid (100%) and van-
comycin (100%). Similarly, S. aureus isolated from 35 (46.1%) samples were found to be biofilm producers. Higher rate 
of inducible clindamycin resistance was seen among MRSA in comparison to methicillin susceptible S. aureus (MSSA). 
Similarly, higher rates of multidrug resistance and methicillin resistance were found among biofilm producing strains 
in comparison to biofilm non producing strains.
Conclusions: The rate of isolation of MRSA from community acquired infections was found to be high in Nepal. 
Increased rate of inducible clindamycin resistance as compared to previous studies in Nepal was noted. So for the 
proper management of the infections caused by S. aureus, D test for the detection of inducible clindamycin resist-
ance should be included in the routine laboratory diagnosis. Further, detection of biofilm production should also be 
included in the routine tests. Linezolid and vancomycin can be used for the preliminary treatment of the serious infec-
tions caused by S. aureus.
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Background
The increasing rates of drug resistance among S. aureus 
to commonly used antibiotics and emergence of methicil-
lin resistant strains for which limited treatment options 
exist have created a great problem to the management of 
the infections caused by S. aureus [1]. The accurate local 
antibiotic susceptibility data along with knowledge about 
the local prevalence of methicillin resistance may be help-
ful for starting proper preliminary treatment of the infec-
tions caused by S. aureus [1]. The increased prevalence of 
drug resistance mainly methicillin resistance among the 
strains of S. aureus has impelled the usage of macrolide–
lincosamide–streptogramin B (MLSB) antibiotics mainly 
clindamycin for the treatment of the infections caused 
by S. aureus [2]. However, there are reports of increasing 
resistance to MLSB therapy particularly to clindamycin 
due to haphazard use of these antibiotics [2]. The induc-
ible clindamycin resistance is responsible for treatment 
failure of the infections caused by S. aureus treated with 
clindamycin, as it can not be detected in the routine labo-
ratory tests if the erythromycin and clindamycin are not 
kept adjacent to each other while performing antimicro-
bial susceptibility testing [2–4]. D test is one of the easi-
est methods that can be employed to detect the strains of 
S. aureus showing inducible clindamycin resistance.
Similarly, another problem with the treatment of infec-
tions caused by S. aureus is biofilm formation. Biofilm 
formation is a defense mechanism of S. aureus [5]. Bac-
teria protected by biofilms are resistant to host defense 
mechanisms and show resistance to standard antibiotic 
therapy [5].
So, in this study we determined the drug susceptibil-
ity patterns of the strains of S. aureus isolated from pus/
wound swab samples. Further, we also studied the preva-
lence of inducible clindamycin resistance and methicillin 
resistance along with rate of biofilm production.
Methods
A cross sectional descriptive study was conducted among 
the patients attending B & B hospital, Lalitpur, Nepal 
from March 2015 to September 2015. A total of 830 pus/
wound swab samples (400 from inpatients and 430 from 
out patients) received were processed using standard 
microbiological techniques [6]. The colonies grown were 
identified on the basis of colony morphology, Gram’s 
stain, and biochemical tests [7]. Yellow colored colonies 
on mannitol salt agar, which were Gram positive cocci, 
catalase positive, slide and tube coagulase positive, 
hydrolysed gelatin, showed beta-hemolysis on blood agar, 
methyl red positive, Voges–Proskauer positive, nitrate 
reduction positive, fermentative, urease positive, DNase 
producing, lactose, mannitol, maltose, mannose, sucrose 
and trehalose fermenting, alkaline phosphatase positive 
were confirmed as S. aureus. Antimicrobial susceptibil-
ity testing was performed by Kirby Bauer disc diffusion 
technique following clinical and laboratory standards 
institute (CLSI) guidelines [8]. The concentration of sus-
pension of the test organism was made equivalent to 0.5 
McFarland standards. And lawn culture was performed 
on Mueller–Hinton agar plate. Then the antibiotic discs 
were placed over the lawn culture and the plate was incu-
bated aerobically at 35 °C for 24 h. Finally the plate was 
observed for zone of inhibition and interpreted according 
to CLSI guidelines. The antibiotic discs used were peni-
cillin-G (10 units), cefoxitin (30 μg), ciprofloxacin (5 μg), 
clindamycin (2  μg), chloramphenicol (30  μg), erythro-
mycin (15  μg), gentamicin (10  μg), tetracycline (30  μg), 
cotrimoxazole (25 μg), vancomycin (30 μg) and linezolid 
(30 μg). Strains showing resistance to three or more than 
three different classes of antibiotics were considered mul-
tidrug resistant [9].
Detection of methicillin resistant S. aureus
The strains of methicillin resistant S. aureus were 
detected by determination of minimum inhibitory 
concentration of oxacillin by agar dilution method [8, 
10]. Different concentrations of oxacillin ranging from 
0.0625 to 32 μg/ml were prepared. One milliliter of each 
of these concentrations was added to 19  ml of Muel-
ler–Hinton agar cooled to around 50  °C and allowed to 
solidify in sterilized petri plates. Then the concentration 
of the broth containing test organism was adjusted to 0.5 
McFarland standards. Prior to inoculation, further (1:10) 
dilution of the broth containing test organism was per-
formed. The plates were then inoculated with the test 
organisms and were incubated aerobically at 35  °C for 
24 h, which were then examined for bacterial growth and 
interpreted according to CLSI guidelines.
Screening of inducible clindamycin resistance in S. aureus
The inducible clindamycin resistance was detected by D 
test [8]. Erythromycin (15 μg) disc and clindamycin (2 µg) 
disc were placed 15–26 mm edge to edge apart in Muel-
ler–Hinton agar plate inoculated with the test isolate. The 
plates were incubated aerobically at 35  °C for 16–18  h. 
Flattening of the zone of inhibition of clindamycin adjacent 
to the erythromycin disc was regarded as D test positive.
Screening of biofilm production among the strains of S. 
aureus
The detection of biofilm production among the strains 
of S. aureus was performed by microtiter plate method 
[11]. The S. aureus was grown in 96 welled microtiter 
plate containing trypticase soya broth with 2% glucose, at 
35  °C for 48 h. The optical density value of the bacteria 
that coat the wall of the wells was determined with the 
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help of enzyme linked immunosorbent assay reader after 
staining with crystal violet. The organisms were identi-
fied as biofilm producer or biofilm non producer on the 
basis of the observed optical density values.
For quality control S. aureus ATCC 25923 was used.
Data analysis
For data analysis SPSS version 21.0 was used. Chi square 
test was applied and p value <0.05 was considered statis-
tically significant.
Results
Among total 830  pus/wound swab samples processed, 
364 (43.9%) were culture positive. Out of which, S. aureus 
was isolated from 76 (20.9%) samples. Among the 76 S. 
aureus isolated, 45 (59.2%) were MDR, 36 (47.4%) were 
MRSA, 17 (22.4%) were D test positive and 35 (46.1%) 
were biofilm producers.
Out of 76 S. aureus isolated, 43 (56.6%) were isolated 
from outpatients, whereas 33 (43.4%) were isolated from 
inpatients. Among the S. aureus isolated from outpa-
tients, 41.9% were MRSA, while among the S. aureus iso-
lated from inpatients 54.5% were MRSA.
Antimicrobial susceptibility patterns of S. aureus isolated
Among all the S. aureus, highest rates of susceptibil-
ity were seen toward linezolid (100%) and vancomycin 
(100%) followed by tetracycline (98.7%) and chloram-
phenicol (94.7%) (Table 1).
Inducible clindamycin resistance among strains of S. aureus
Among 76 S. aureus, inducible macrolide–lincosamide–
streptogramin B (MLSB) resistance, constitutive MLSB 
resistance and macrolide–streptogramin B (MSB) resist-
ance were seen in 17 (22.4%), 8 (10.5%) and 17 (22.4%) 
S. aureus respectively. Inducible MLSB resistance was 
higher among MRSA in comparison to MSSA (p < 0.05) 
(Table 2).
Biofilm production among S. aureus
Thirty five (46.1%) S. aureus were found to be biofilm 
producers. Out of which, 23 (65.7%) were MRSA and 
24 (68.6%) were MDR. Among 41 (53.9%) biofilm non 
producers, 13 (31.7%) were MRSA and 21 (51.2%) were 
MDR.
Discussion
Similar rates of MRSA as in our study were reported by 
Shrestha et al. (44.9%) [12] and Ansari et al. (43.1%) [13]. 
In our study, higher percent of MRSA isolates were iso-
lated from admitted patients. The colonized health care 
workers in the hospitals are the main sources of MRSA 
in hospitalized patients causing higher rates of infections 
among them [14]. However, the rate of isolation of MRSA 
among the out patients was also very high (41.9%). This 
high rate of community acquired MRSA infections indi-
cates a frightening situation. The main source for the 
community acquired MRSA infections may be the colo-
nized health care workers who transfer the MRSA to 
their household, spreading it to the community [14]. Fur-
ther, the admitted patients who got colonized during hos-
pital stay may also act as the alternative sources for the 
community acquired MRSA infections.
In our study, the rate of inducible clindamycin resist-
ance was found to be 22.4%, which was very high in 
comparison to the rates reported in previous studies by 
Ansari et  al. (12.4%) [13] and Adhikari et  al. (10%) [15] 
in Nepal. Such difference could be due to the difference 
in resistance patterns of S. aureus in different patient 
groups, hospitals, time periods and geographical loca-
tions [12]. This showed the increasing prevalence of 
inducible clindamycin resistance among the clinical iso-
lates of S. aureus in Nepal. We reported higher rate of 
inducible clindamycin resistance among the strains of 
MRSA in comparison to the strains of MSSA, which was 
in accordance to the result reported by Shrestha et  al. 
[12]. Clindamycin is considered as one of the drugs of 
choice for treatment of the infection caused by MRSA 
[13]. But due to increasing rates of inducible clindamy-
cin resistance among strains of S. aureus mainly MRSA, 
there is high chance of treatment failure if clindamycin is 
used for the treatment of the infections caused by strains 
showing inducible clindamycin resistance [1]. So, a sim-
ple test like D test for detection of inducible clindamycin 
resistance is crucial to guide the treatment of the infec-
tions caused by S. aureus and is recommended to include 
in the routine laboratory tests.
As in a study by Ansari et al. (94.7%) [13], high rate 
of resistance to penicillin (97.4%) was reported in 
Table 1 Antimicrobial susceptibility patterns of  S. aureus 
isolates
Antibiotics MRSA (n = 36) MSSA (n = 40) Total (n = 76)
Penicillin 0 (0%) 2 (5%) 2 (2.6%)
Cefoxitin 0 (0%) 40 (100%) 40 (52.6%)
Ciprofloxacin 8 (22.2%) 13 (32.5%) 21 (27.6%)
Cotrimoxazole 10 (27.8%) 18 (45%) 28 (36.8%)
Gentamicin 22 (61.2%) 30 (75%) 52 (68.4%)
Chloramphenicol 35 (97.2%) 37 (92.5%) 72 (94.7%)
Erythromycin 10 (27.8%) 24 (60%) 34 (44.7%)
Clindamycin 32 (88.9%) 36 (90%) 68 (89.5%)
Tetracycline 35 (97.2%) 40 (100%) 75 (98.7%)
Vancomycin 36 (100%) 40 (100%) 76 (100%)
Linezolid 36 (100%) 40 (100%) 76 (100%)
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our study. This is because only a small numbers of 
strains of S. aureus do not produce beta-lactamases 
[13]. We reported similar rate of resistance to cipro-
floxacin (72.4%) as reported by Ansari et  al. (63.7%) 
[13]. However, lower rate of resistance was reported 
toward gentamicin (31.6%) in comparison to the rate 
reported by Ansari et al. (60.4%) [13]. Further, higher 
rate of resistance to erythromycin (55.3%) was noted 
in contrast to 32.7% in a study by Ansari et  al. [13]. 
In addition, resistance to cotrimoxazole was 63.2% 
in comparison to 81.7% noted in a previous study by 
Ansari et  al. [13]. As previous studies in Nepal, no 
resistance was seen toward vancomycin and linezolid 
[13]. But among the commonly used antibiotics, the 
highest rate of susceptibility of S. aureus including 
MRSA, was found toward tetracycline followed by 
chloramphenicol suggesting the possibility of using 
these drugs for preliminary treatment of the infec-
tions caused by S. aureus in our settings. In the devel-
oping countries like Nepal, the low cost of these drugs 
will be an extra benefit.
In our study, higher rates of multidrug resistance and 
methicillin resistance were found among biofilm pro-
ducing strains in comparison to biofilm non produc-
ing strains. These findings were in favor of the results 
reported by Ghasemian et  al. [16]. Due to protective 
nature of the biofilm, the bacteria growing in it are intrin-
sically resistant to many antibiotics [17]. The antibiotic 
resistance among the strains of the bacteria residing in 
biofilm may increase up to 1000 times [17]. The main rea-
sons for this may be difficulty in penetration of biofilm by 
antibiotics, slow growth rate of the bacteria and presence 
of antibiotic degradation mechanisms [17]. Further, bio-
film formation gives platform for horizontal gene trans-
fer among bacteria, causing the spread of drug resistance 
markers and other virulence factors [18].
In this study, due to lack of resources we could not use 
molecular methods to confirm our results but there are 
molecular methods like coagulase (coa) gene detection by 
polymerase chain reaction for identification of S. aureus 
[19] and detection of mecA gene for identification of 
methicillin resistant S. aureus [15].
Conclusions
In our study, high rates of drug resistance among the 
strains of S. aureus to commonly used drugs were 
observed. The rate of isolation of MRSA from commu-
nity acquired infections was found to be high in Nepal. 
Inducible clindamycin resistance is presenting as seri-
ous problem to the management of infections caused by 
S. aureus, as its prevalence is increasing in Nepal. So, D 
test for the detection of inducible clindamycin resistance 
should be included in the routine laboratory diagnosis to 
guide the treatment. Further, keeping in mind the high 
rate of biofilm production among the strains of S. aureus 
and high rate of drug resistance among the biofilm pro-
ducing strains, detection of biofilm formation should 
also be included in the routine tests. On the basis of the 
antimicrobial susceptibility testing report of our study, 
among the commonly used drugs tetracycline and chlo-
ramphenicol can be used for the preliminary treatment of 
the infections caused by S. aureus including MRSA in our 
settings. However, we recommend to use linezolid and 
vancomycin for the preliminary treatment of the serious 
infections caused by S. aureus.
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